Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
See Latest ArticlesStrong IgG antibody responses to Borrelia burgdorferi glycolipids in patients with Lyme arthritis, a late manifestation of the infection
Clinical Immunology, 06/18/09
Jones KL et al. – Data suggest that almost all patients with Lyme arthritis have strong IgG antibody responses to Borrelia burgdorferi glycolipid antigens.
Methods- Aim was to assess the immunogenicity of the membrane lipids of B. burgdorferi using serum samples from human pts with early or late manifestations of Lyme disease
- Membrane lipids of B. burgdorferi were separated into 16 fractions
- Components in each fraction were identified
- Immunogenicity of each fraction was determined by ELISA using sera from Lyme disease pts
- Only the 2 glycolipids, acylated cholesteryl galactoside (ACG, BbGL-I) and monogalactosyl diacylglycerol (MgalD, BbGL-II), were immunogenic
- Early in the infection, 29% of pts who were convalescent from erythema migrans and 19/35 pts (54%) with neuroborreliosis had weak IgG responses to purified MgalD
- A smaller percentage of pts had early responses to synthetic ACG
- However, almost all of 75 pts with Lyme arthritis, a late disease manifestation, had strong IgG reactivity with both glycolipids
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study
Arthritis Research & Therapy, 10/16/09
The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: A prospective study
Arthritis & Rheumatism, 11/04/09
Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research , 11/02/09
Today in Infectious Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Rheumatoid Arthritis and Tuberculous Arthritis: Differentiating MRI Features
American Journal of Roentgenology, 10/26/09
CD23 mediates anti-mycobacterial activity of human macrophages
Infection and Immunity, 10/20/09
Arthroscopic synovectomy, an alternative in the treatment of brucellar arthritis of the knee with prolonged course. A report of two cases
The Internet Journal of Orthopedic Surgery, 10/12/09
Today in Other Arthritis...keeping you current
Receive free subspecialty "5-minute updates" via email
Follow-up results of 702 patients receiving tumor necrosis factor-alpha antagonists and evaluation of risk of tuberculosis
Rheumatology International, 10/26/09
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
Annals of Rheumatic Diseases, 10/12/09
The beneficial effects of a 3 week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: Results of the STIVEA trial
Annals of Rheumatic Diseases, 10/23/09
Sponsor
Article Search
Sponsor